Aloia Quijano

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 2

Top Topics

Angiotensin Converting Enzyme

Top Venues

Antioxidants (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Jose Luis Labandeira-Garcia, Carmen M Labandeira, Rita Valenzuela, Maria A Pedrosa, Aloia Quijano, Ana Isabel Rodriguez-Perez
Drugs Modulating Renin-Angiotensin System in COVID-19 Treatment. Biomedicines 10 (2) (2022)
Aloia Quijano, Carmen Diaz-Ruiz, Andrea Lopez-Lopez, Begoña Villar-Cheda, Ana Muñoz, Ana Isabel Rodriguez-Perez, Jose Luis Labandeira-Garcia
Angiotensin Type-1 Receptor Inhibition Reduces NLRP3 Inflammasome Upregulation Induced by Aging and Neurodegeneration in the Substantia Nigra of Male Rodents and Primary Mesencephalic Cultures. Antioxidants (Basel, Switzerland) 11 (2) (2022)